发明名称 MMP inhibitors
摘要 Novel compounds according to formula In is 0, 1, 2 or 3;X represents hydroxamic acid (CONHOH), carboxylic acid, phosphonic acid, acetylthiomethyl group or a mercaptomethyl group; R2, R10 and R11 independently represent hydrogen or (C1-8)alkyl, (C2-6)alkenyl, (C3-8)cycloalkyl, aryl(C0-6)alkyl or heteroaryl(C0-6)alkyl, all of which may optionally be substituted; R3 and R4 independently represent hydrogen, hydroxy or alkoxy; provided that if A, A', Z and R5 are all bonds, and s and t are both 0 (zero), then R6 is different from hydrogen, and that at least one of R3, R4, R10 and R11 is different from hydrogen;or a salt, hydrate or solvate thereof; pharmaceutical compositions comprising said compound; therapeutical methods comprising administering said compounds; andthe use of said compounds in the manufacture of medicaments.
申请公布号 US6784169(B2) 申请公布日期 2004.08.31
申请号 US20030345304 申请日期 2003.01.16
申请人 LEO PHARMACETICAL PRODUCTS LTD. 发明人 CHRISTENSEN METTE KNAK;BLAEHR LARS KRISTIAN ALBERT
分类号 A61K31/675;A61P1/02;A61P1/04;A61P9/00;A61P9/04;A61P11/06;A61P17/00;A61P17/06;A61P19/00;A61P19/02;A61P19/10;A61P25/28;A61P27/02;A61P27/06;A61P29/00;A61P31/04;A61P35/00;A61P35/04;A61P43/00;C07F;C07F9/6584;(IPC1-7):A61K31/66;C07F9/02 主分类号 A61K31/675
代理机构 代理人
主权项
地址